Colloidal systems toward 3D cell culture scaffolds.
Christian Vila-Parrondo1, Clara García-Astrain1, Luis M Liz-Marzán2
1CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo de Miramon 182, 20014 Donostia San Sebastián, Spain.
Advances in Colloid and Interface Science
|August 22, 2020
Summary
Hierarchical scaffolds with controlled porosity are key for tissue engineering. Colloidal fabrication advances these biomaterials for better cell interactions, tissue regeneration, and drug delivery applications.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Three-dimensional porous scaffolds are crucial for mimicking natural tissue microenvironments in tissue engineering.
- Effective scaffolds require ordered, interconnected porosity, mechanical strength, and biocompatibility to support cell growth and vascularization.
- Hierarchical scaffolds offer controlled porosity, microstructure, and morphology for advanced applications.
Purpose of the Study:
- To review recent advances in the colloidal fabrication of hierarchical porous scaffolds.
- To outline the essential requirements for scaffolds in biomedical applications.
- To discuss the potential of these scaffolds in tissue regeneration and drug delivery.
Main Methods:
- Review of recent literature on colloidal fabrication techniques for hierarchical scaffolds.
- Analysis of scaffold properties influencing cell behavior and tissue integration.
- Examination of case studies in tissue regeneration and drug delivery.
Main Results:
- Colloidal fabrication enables precise control over scaffold architecture, including porosity and morphology.
- Hierarchical scaffolds demonstrate significant potential in promoting cell-matrix and cell-cell interactions.
- Scaffolds exhibit versatility and biocompatibility across various tissue regeneration applications.
Conclusions:
- Colloidal fabrication is a promising strategy for creating advanced hierarchical scaffolds.
- Optimized scaffold design is critical for successful tissue engineering and regenerative medicine.
- Further research is needed to address limitations and challenges for broader clinical translation.


